Temporal Drivers of Opioid-Related ED Visits: An Ensemble Machine Learning Study With Consensus-Based Feature
R Jerome Dixon1,2, Elvin T Price1,3
1Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia, USA.
Clinical and Translational Science
|August 2, 2026
Summary
This study identifies key risk factors for emergency department visits due to prescription opioid use disorder (OUD), incorporating pharmacogenomic data and temporal analysis. Findings highlight gabapentin and long-term opioid use as critical predictors, informing targeted interventions.
Area of Science:
- Health Informatics
- Pharmacogenomics
- Public Health
Background:
- Identifying modifiable risk factors for prescription opioid use disorder (OUD)-related emergency department (ED) visits is crucial.
- Existing models often lack pharmacogenomic (PGx) data and robust feature validation.
Purpose of the Study:
- To develop and validate a predictive model for prescription OUD-related ED visits using comprehensive claims data.
- To incorporate pharmacogenomic burden and pre-index temporal dynamics into risk prediction.
- To identify actionable risk features and optimal intervention timing.
Main Methods:
- Analysis of Virginia All-Payer Claims Database (2016-2019) for 6,929,576 patients.
- Machine learning models (CatBoost, XGBoost, XGBoost-RF) trained on PGx burden and temporal dynamics.
- Consensus Filter (SHAP ∩ FFA) and Dynamic Time Warping (DTW) for risk feature identification and trajectory analysis.
Main Results:
- The model achieved significant predictive lift (2.3× to 3.4×) and an AUROC of 0.800 in the 25-44 age band.
- Top risk features included gabapentin, long-term opioid use (Z79.891), and pharmacogenomic drug burden (pgx_num_drugs).
- DTW identified three distinct utilization archetypes with a mean pre-index time-to-target of 6.8 months.
Conclusions:
- The study provides an observational framework for risk attribution in prescription OUD-related ED care.
- Findings specify intervention targets (medication, care) and optimal timing (surveillance windows).
- The association-versus-causation distinction is maintained to support clinical use and future causal validation.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...

